Location: London, UK
Start Date: November 7, 2019
End Date: November 8, 2019
Oxford Global is proud to introduce the Inaugural Digital PCR Congress, 7 – 8 November 2019, London, UK which will bring together key leaders and influencers from global pharmaceutical organisations and leading academic research institutions. Learn about the advantages of digital PCR in infectious disease diagnosis and detection of cancer and discover solutions for the integration of digital PCR with NGS, Genome Editing and novel digital PCR technologies. Our interactive workshop on Circulating Tumour DNA Analysis: Moving Towards Precision Oncology is hosted by stakeholders from both pharma and academia, providing a unique insight into the specific digital PCR and NGS techniques laboratories are using to overcome the challenges in the analysis of ctDNA in cancer patients. On day 2, our exclusive focus session on digital PCR in oncology detection, diagnosis, monitoring and treatment includes an unparalleled range of cancers and reflects current trends in industry and academia.
The two-day congress offers an intuitive platform for high level scientific and business discussions, ensuring valuable networking and interactive sessions. Join over 600 senior level delegates and benefit from the co-located structure of our SynGen Series UK events.
View the agenda: https://bit.ly/2osgkiO
For more information about the programme and registration, please contact Emily Hawkings at email@example.com or visit the website: https://bit.ly/2mUvVHK
Go Social: Join our qPCR & Digital PCR Networking Group on LinkedIn, follow us on Twitter @xgenseq & join the conversation at #GENSERIESUK19